US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 0.464
  • +0.064+16.00%
Close Mar 11 16:00 ET
  • 0.450
  • -0.014-3.00%
Post 16:05 ET
19.37MMarket Cap-0.30P/E (TTM)

About Carisma Therapeutics Company

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Company Profile

SymbolCARM
Company NameCarisma Therapeutics
Listing DateFeb 6, 2014
Founded2016
CEOMr. Steven Kelly
MarketNASDAQ
Employees107
Fiscal Year Ends12-31
Address3675 Market Street,Suite 200
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19104

Company Executives

  • Name
  • Position
  • Salary
  • Steven Kelly
  • Director, President and Chief Executive Officer
  • 3.50M
  • Dr. Michael Klichinsky, PhD,Pharm.D.
  • Chief Scientific Officer
  • 1.60M
  • Natalie McAndrew
  • Interim Vice President of Finance, Principal Financial Officer and Principal Accounting Officer
  • --
  • Sanford S. Zweifach
  • Chairman of the Board
  • 271.55K
  • Dr. David T. Scadden, M.D.
  • Director
  • --
  • Marella Thorell
  • Director
  • --
  • Sohanya Roshan Cheng, M.B.A.
  • Director
  • --
  • Dr. John A. Hohneker, M.D.
  • Independent Director
  • --
  • Dr. Briggs W. Morrison, M.D.
  • Independent Director
  • 220.20K
Trending Stocks
Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.